These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pediatric malignancies provide unique cancer therapy targets. Uren A; Toretsky JA Curr Opin Pediatr; 2005 Feb; 17(1):14-9. PubMed ID: 15659957 [TBL] [Abstract][Full Text] [Related]
6. Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment. Hsi ED Leuk Lymphoma; 2008 Sep; 49(9):1668-80. PubMed ID: 18798102 [TBL] [Abstract][Full Text] [Related]
7. Advances in paediatric cancer treatment. Saletta F; Seng MS; Lau LM Transl Pediatr; 2014 Apr; 3(2):156-82. PubMed ID: 26835334 [TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of pediatric and adolescent HIV infection. Schuval SJ Ther Clin Risk Manag; 2009 Jun; 5(3):469-84. PubMed ID: 19707256 [TBL] [Abstract][Full Text] [Related]
9. Emerging strategies in the management of cancer. Rieger PT Oncol Nurs Forum; 1997 May; 24(4):728-37. PubMed ID: 9159787 [TBL] [Abstract][Full Text] [Related]
10. The genomics of acute myeloid leukemia in children. Conneely SE; Rau RE Cancer Metastasis Rev; 2020 Mar; 39(1):189-209. PubMed ID: 31925603 [TBL] [Abstract][Full Text] [Related]
11. Dual Biologic or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease (DOUBLE-PIBD): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN. Yerushalmy-Feler A; Olbjorn C; Kolho KL; Aloi M; Musto F; Martin-de-Carpi J; Lozano-Ruf A; Yogev D; Matar M; Scarallo L; Bramuzzo M; de Ridder L; Kang B; Norden C; Wilson DC; Tzivinikos C; Turner D; Cohen S Inflamm Bowel Dis; 2024 Feb; 30(2):159-166. PubMed ID: 37042978 [TBL] [Abstract][Full Text] [Related]
12. Advances in the Treatment of Pediatric Bone Sarcomas. Grohar PJ; Janeway KA; Mase LD; Schiffman JD Am Soc Clin Oncol Educ Book; 2017; 37():725-735. PubMed ID: 28561686 [TBL] [Abstract][Full Text] [Related]
13. Syntactic structure analysis in invasive breast cancer: analysis of reproducibility, biologic background, and prognostic value. van Diest PJ; Fleege JC; Baak JP Hum Pathol; 1992 Aug; 23(8):876-83. PubMed ID: 1644433 [TBL] [Abstract][Full Text] [Related]
14. Complications of biologic therapy for pediatric cancer - What the surgeon needs to know. Malek MM Semin Pediatr Surg; 2019 Dec; 28(6):150863. PubMed ID: 31931961 [TBL] [Abstract][Full Text] [Related]
15. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in ovarian cancer. Friedlander ML Semin Oncol; 1998 Jun; 25(3):305-14. PubMed ID: 9633842 [TBL] [Abstract][Full Text] [Related]
17. Evolving paradigms for new agent development in pediatric oncology. Flynn A; Fox E Curr Opin Pediatr; 2018 Feb; 30(1):10-16. PubMed ID: 29176356 [TBL] [Abstract][Full Text] [Related]
18. Risk assignment in pediatric soft-tissue sarcomas: an evolving molecular classification. Qualman SJ; Morotti RA Curr Oncol Rep; 2002 Mar; 4(2):123-30. PubMed ID: 11822984 [TBL] [Abstract][Full Text] [Related]
19. Dual Biologic Therapy in a Patient With Niemann-Pick Type C and Crohn Disease: A Case Report and Literature Review. Hudson AS; Almeida P; Huynh HQ JPGN Rep; 2022 Aug; 3(3):e225. PubMed ID: 37168644 [TBL] [Abstract][Full Text] [Related]
20. Recent advances in systemic therapy: advances in adjuvant systemic chemotherapy of early breast cancer. López-Tarruella S; Martín M Breast Cancer Res; 2009; 11(2):204. PubMed ID: 19344489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]